中国神经再生研究（英文版）文献汇览

文献>文献汇览

1CALL FOR PAPERS封2

2Heterogeneous populations of neural stem cells contribute to myelin repairINVITED REVIEWS509-517

3Axon degeneration: make the Schwann cell great againINVITED REVIEWS518-524

4RhoA as a target to promote neuronal survival and axon regenerationINVITED REVIEWS525-528

5The reasons for end-to-side coaptation: how does lateral axon sprouting work?INVITED REVIEWS529-533

6Phosphatidylserine improves axonal transport by inhibition of HDAC and has potential in treatment of neurodegenerative diseasesINVITED REVIEWS534-537

7The complexities underlying age-related macular degeneration: could amyloid beta play an important role?INVITED REVIEWS538-548

8Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapyINVITED REVIEWS549-557

9Endothelial progenitor cells as a therapeutic option in intracerebral hemorrhageINVITED REVIEWS558-561

10A tale of motor neurons and CD4+ T cells: moving forward by looking backINVITED REVIEWS562-565

11Analyzing the role of extracellular matrix during nervous system development to advance new regenerative strategiesPERSPECTIVES566-567

12Nerves and hydrogen peroxide:how old enemies become new friendsPERSPECTIVES568-569

13Ghosts in the shell: identification of microglia in the human central nervous system by P2Y12 receptorPERSPECTIVES570-571

14RhoA/ROCK activation in major pelvic ganglion mediates caspase-3 dependent nitrergic neuronal apoptosis following cavernous nerve injuryPERSPECTIVES572-573

15Why and how does light therapy offer neuroprotection in Parkinson's disease?PERSPECTIVES574-575

16Delivery of therapeutics to posterior eye segment: cell-encapsulating systemsPERSPECTIVES576-577

17Role of the STRIPAK complex and the Hippo pathway in synaptic terminal formationPERSPECTIVES578-579

18Regulatory role of microRNA on inflammatory responses of diabetic retinopathyPERSPECTIVES580-581

19Food, polyphenols and neuroprotectionPERSPECTIVES582-583

20Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degenerationPERSPECTIVES584-585